The story behind my most recent manuscript on SARS-CoV-2 sample pooling strategies is a long one. What started as a small side project aimed at facilitating the COVID-19 pandemic response became a publication effort with an extraordinarily enduring submission endeavor.
Patients' characteristics might also influence the efficacy of vaccines against COVID-19. We show that poor glycaemic control is associated with a decreased immune response to Pfizer vaccine and also with an increased incidence of breakthrough infections in patients with Type 2 Diabetes.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
The Nature Portfolio Health Community provides a forum for all those interested in health and disease research to share the latest discoveries, news, and opinions; from disease modelling through to digital medicine approaches.